Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Carcinoma, Intraductal, Noninfiltrating 4Carcinoma, Ductal, Breast 3Breast Carcinoma In Situ 2Stomach Neoplasms 1Skin Abnormalities 1Radiodermatitis 1Radiation Injuries 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Inflammation 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Low-Level Light Therapy 5Petrolatum 2dimethicone 1Triamcinolone Acetonide 1Thioctic Acid 1Standard of Care 1Silver Sulfadiazine 1Radiotherapy, Conformal 1Radiotherapy 1Practice Guidelines as Topic 1Melatonin 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Dimethyl Sulfoxide 1Curcumin 1Centella asiatica extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiodermatitis × Radiotherapy, Conformal × Breast × Clear all
NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Biogen

Phase 2 Completed
187 enrolled 11 charts
Breast

Breast Neoplasms, Inflammation, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡